Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Women With Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00019435
What this trial is testing

LMB-9 Immunotoxin in Treating Patients With Advanced Solid Tumors

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+4 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00096343
What this trial is testing

Paclitaxel and Carboplatin in Treating Women Who Are Undergoing Surgery for Newly Diagnosed, Locally Advanced Breast Cancer

Who this might be right for
Breast Cancer
University of Alabama at Birmingham 31
Very early researchStudy completedNCT02352025
What this trial is testing

S-equol in Women With Triple Negative Breast Cancer

Who this might be right for
Breast Cancer
The University of Texas Health Science Center at San Antonio 39
Not applicableLooking for participantsNCT06461650
What this trial is testing

Preoperative Nicotine Cessation for Women With Breast Cancer Recommended for Reconstruction

Who this might be right for
Breast Cancer
University of Florida 20
Testing effectiveness (Phase 2)Study completedNCT02344550
What this trial is testing

Study of GnRH-A [Leuprorelin(Lorelin Depot] Plus Leterozole +/- Everolimus for Premenopausal Women With Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Asan Medical Center 137
Not applicableStudy completedNCT03860740
What this trial is testing

Effect of Physical Exercise on Tumor Proliferation of Luminal B Breast Cancer Patients

Who this might be right for
Breast CancerLuminal B
Spanish Breast Cancer Research Group 12
Large-scale testing (Phase 3)Ended earlyNCT00004935
What this trial is testing

Herceptin Followed by Chemotherapy in Treating Women With Metastatic Breast Cancer That Overexpresses HER2

Who this might be right for
Breast Cancer
Swiss Cancer Institute 175
Testing effectiveness (Phase 2)WithdrawnNCT04675450
What this trial is testing

NBP in Women With Metastatic Breast Cancer to Prevent Nab-paclitaxel Induced Toxic Neuropathy

Who this might be right for
Breast CancerPeripheral Neuropathy
Conjupro Biotherapeutics, Inc.
Large-scale testing (Phase 3)UnknownNCT00005581
What this trial is testing

Combination Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer

Who this might be right for
Breast Cancer
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy 1,000
Testing effectiveness (Phase 2)Study completedNCT01671319
What this trial is testing

Dose Dense TC + Pegfilgrastim Support for Breast Cancer

Who this might be right for
Female Breast Cancer
University of Wisconsin, Madison 42
Not applicableStudy completedNCT07472036
What this trial is testing

Improving Breast Cancer Screening Uptake Through Tailored Reminder Letters

Who this might be right for
Health BehaviorBreast Cancer ScreeningMammography
Universiteit Antwerpen 7,947
Large-scale testing (Phase 3)Study completedNCT00002564
What this trial is testing

Nutrition Intervention in Treating Women With Breast Cancer

Who this might be right for
Breast Cancer
Institute for Cancer Prevention (IFCP) 2,500
Post-approval studies (Phase 4)Ended earlyNCT00754767
What this trial is testing

L-Carnitine L-Tartrate in Preventing Peripheral Neuropathy Caused By Chemotherapy in Women With Metastatic Breast Cancer

Who this might be right for
Breast CancerChemotherapeutic Agent ToxicityNeurotoxicity
HealthPartners Institute 2
Not applicableWithdrawnNCT00083044
What this trial is testing

Ductal Lavage in Assessing Women With Early Breast Cancer or at High Risk of Developing Breast Cancer and Who Are Eligible For Tamoxifen Therapy

Who this might be right for
Breast Cancer
Northwestern University
Large-scale testing (Phase 3)UnknownNCT05439499
What this trial is testing

This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c Versus Placebo in Combination With Letrozole or Anastrozole ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer.

Who this might be right for
Advanced Breast CancerFemale Breast Cancer
Ahon Pharmaceutical Co., Ltd. 434
Early research (Phase 1)Study completedNCT03689192
What this trial is testing

Arginase-1 Peptide Vaccine in Patients With Metastatic Solid Tumors

Who this might be right for
Non Small Cell Lung CancerUrothelial CarcinomaMalignant Melanoma+5 more
Herlev Hospital 13
Large-scale testing (Phase 3)Study completedNCT00944918
What this trial is testing

Study of Faslodex With or Without Concomitant Arimidex Versus Exemestane Following Progression on Non-steroidal Aromatase Inhibitors (NSAI)

Who this might be right for
Progression-free Survival
AstraZeneca 25
Early research (Phase 1)WithdrawnNCT04498520
What this trial is testing

Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+32 more
Pamela Munster
Very early researchEnded earlyNCT04379024
What this trial is testing

Pilot Study of Effects of Duavee® on Imaging and Blood Biomarkers In Women With Menopausal Symptoms

Who this might be right for
Focus of Study is Healthy Women at Risk for Breast Cancer
Carol Fabian, MD 11
Not applicableActive Not RecruitingNCT07475325
What this trial is testing

Individual Factors Associated With Care Pathways Delays in Breast Cancer in Hauts-de-France.

Who this might be right for
Breast CancerInvasive Breast Carcinoma
University Hospital, Lille 500
Next Page